0001279569-23-000434.txt : 20230407 0001279569-23-000434.hdr.sgml : 20230407 20230406173855 ACCESSION NUMBER: 0001279569-23-000434 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230406 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230407 DATE AS OF CHANGE: 20230406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Charlotte's Web Holdings, Inc. CENTRAL INDEX KEY: 0001750155 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 981508633 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56364 FILM NUMBER: 23807297 BUSINESS ADDRESS: STREET 1: 700 TECH COURT CITY: LOUISVILLE STATE: CO ZIP: 80027 BUSINESS PHONE: 1-720-617-7303 MAIL ADDRESS: STREET 1: 700 TECH COURT CITY: LOUISVILLE STATE: CO ZIP: 80027 8-K 1 form8k.htm FORM 8-K
0001750155 false A1 true 0001750155 2023-04-06 2023-04-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 6, 2023

 

 

Charlotte’s Web Holdings, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

British Columbia 000-56364 98-1508633

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

700 Tech Court

Louisville, Colorado

80027
(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: (720617-7303

 

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of exchange on which registered
N/A N/A N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 
 
 
Item 8.01.Other Events.

 

On April 6, 2023, Charlotte’s Web Holdings, Inc. (the “Company”), issued a press release announcing the formation of a joint venture with AJNA BioSciences PBC (“AJNA”), and a subsidiary of British American Tobacco PLC (LSE: BATS and NYSE: BTI) (“BAT”). BAT holds a 20% equity interest in the joint venture in the form of preferred units following its US$10 million investment and has the right to participate in future equity issuances to maintain its pro rata equity position. The Company and AJNA each hold 40% of the joint venture’s voting common units.

The Company’s contribution to the joint venture is a license permitting the use certain proprietary hemp intellectual properties, including clinical and consumer data and BAT is contributing US$10 million as the JV’s initial investor. AJNA is contributing laboratory and regulatory services, clinical expertise and the provision of clinical services. The joint venture is expected to use the initial US$10 million investment for the clinical development of a novel hemp botanical Investigational New Drug application and to commence Phase I clinical development in 2023.

BT DE Investments, Inc., a wholly-owned subsidiary of BAT, holds approximately $56.8 million (Canadian Dollar C$75.3 million) in convertible debenture convertible into 19.9% ownership of the Company’s Common Shares at a conversion price of C$2.00 per Common Share of the Company. AJNA, a botanical drug development company focused on mental health and neurological disorders, is partially owned and was co-founded by Joel Stanley, AJNA’s president and the former CEO and Chairman of the board of Company, together with certain other founding members of the Company.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.
  (d) Exhibits:
     

 

     
Exhibit
No.
 

Description

 
   
99.1   Press Release dated April 6, 2023  
104   Cover Page Interactive Data File (embedded within the Inline XBRL document      
           

 

 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    CHARLOTTE’S WEB HOLDINGS, INC.
       
Date: April 6, 2023   By: /s/ Stephen Rogers
      Stephen Rogers
      Senior Vice President - General Counsel and Corporate Secretary
       

 

EX-99.1 2 ex991.htm PRESS RELEASE DATED APRIL 6, 2023

Exhibit 99.1

 

 

Charlotte's Web forms Joint Venture with BAT and AJNA BioSciences to

Seek FDA-Approval for Proprietary Full Spectrum

Hemp Extract Botanical Drug

 

BAT acquires 20% stake for US$10 million, with Charlotte's Web and AJNA each owning 40%

 

Renowned neurologist Dr. Orrin Devinsky, Chief Medical Advisor for AJNA, to lead the project

 

DENVER – April 6, 2023 – (TSX:CWEB, OTCQX:CWBHF), Charlotte’s Web Holdings, Inc. (“Charlotte’s Web,” “CW” or the “Company”), the market leader in full-spectrum hemp extract wellness products, today announced it has formed a joint venture (the “JV”) with AJNA BioSciences PBC (“AJNA”), a botanical drug development company focused on mental health and neurological disorders , and a subsidiary of British American Tobacco PLC (LSE: BATS and NYSE: BTI) (“BAT”), which is contributing US$10 million as the JV’s initial investor. AJNA is partially owned and was co-founded by its president, Joel Stanley, the former CEO and Chairman of the board of Charlotte’s Web, together with certain other founding members of CW.

 

The JV was established to pursue FDA-approval for a novel botanical drug to target a neurological condition identified by the JV leadership team, which will be comprised of CW, AJNA and BAT representatives. This novel botanical drug will be developed from certain proprietary hemp genetics of CW. The JV plans to engage with the FDA to file an Investigational New Drug (“IND”) application and commence Phase I clinical development in 2023.

 

BAT holds a 20% equity interest in the form of preferred units following its US$10 million investment and has the right to participate in future equity issuances to maintain its pro rata equity position. Charlotte’s Web and AJNA each hold 40% of the JV’s voting common units. This is in consideration of contribution by CW of a license permitting the JV to use certain proprietary hemp intellectual properties, including clinical and consumer data, and by AJNA of laboratory and regulatory services, clinical expertise and the provision of clinical services. The JV plans to use the initial US$10 million investment for the clinical development of a novel hemp botanical IND.

 

Orrin Devinsky, M.D., Ph.D., renowned neurologist and researcher and AJNA’s Chief Medical Advisor, will lead the JV’s clinical and regulatory strategy. Dr. Devinsky is an early stakeholder in AJNA and is the Director of New York University (NYU) Langone’s Comprehensive Epilepsy Center and a Professor of Neurology, Neurosurgery, and Psychiatry at NYU Grossman School of Medicine. He was a principal investigator for the development of the cannabis-based FDA approved drug, Epidiolex®. Epidolex was approved in 2018 for the treatment of seizure disorders, Dravet and Lennox-Gastaut syndromes, which are rare and severe forms of pediatric epilepsy.

 

“As one of the first clinicians to research novel cannabinoids, I am very excited to work on this project. I believe the properties of cannabis and hemp are well suited for the FDA's new Botanical Drug Development pathway”, Dr. Devinsky said.

 

Jacques Tortoroli, CEO of Charlotte’s Web said, “This joint venture is a capital efficient way for Charlotte’s Web to unlock the value of its intellectual property to advance development of effective botanical alternatives to current neurological pharmaceuticals.”

 

 
 

 

James Barrett, Commercial Director of Wellbeing and Stimulation at BAT, said: “Our investment in the Joint Venture reinforces our commitment to Charlotte’s Web and represents another step for BAT in our exploration beyond tobacco and nicotine. We continue to transform our business, through strategic investments in innovative consumer, new sciences and technology businesses, as part of our purpose to build A Better Tomorrow.”

 

Subscribe to Charlotte's Web investor news.

 

Related Party Transaction

Due to its ownership of a US$56.8 million convertible debenture of the Company (the “Debenture”), which is convertible into 19.9% ownership of the common shares of the Company (the “Common Shares”) at a conversion price of C$2.00 per Common Share, BAT is considered a “related party” to the Company under applicable securities laws. As such, the formation of the JV (the “Transaction”) will constitute a “related party transaction” within the meaning ‎of Multilateral Instrument 61-101 - Protection of Minority Shareholders in Special ‎Transactions (“MI 61-101”). ‎In the absence of exemptions, the Company would be required to obtain a formal ‎valuation for, and minority shareholder approval of, the “related party transaction”. For ‎the Transaction, the Company intends to rely on the exemption from the formal ‎valuation requirements and the minority ‎shareholder approval requirements of MI 61-101 contained in Section 5.5(a) and Section 5.7(1)(a) of MI 61-101 (Fair Market Value Not More Than 25% of Market Capitalization), respectively, on the basis that neither (A) the fair market value of the subject matter of, nor (B) the fair market value of the ‎consideration for, the Transaction, insofar as it involves interested parties, exceeds 25% of the ‎market capitalization of the Company, as determined by the Company’s board of directors acting in good faith, in accordance with MI 61-101‎.‎

 

Further details will be included in a material change report to be filed by the Company. The material ‎change report will be filed no more than 21 days prior to closing of the Transaction due to the ‎timing of the announcement of the Transaction and the anticipated closing thereof occurring in ‎less than 21 days.‎‎

 

 

About BAT

BAT is a leading, multi-category consumer goods business with a purpose to build A Better Tomorrow™ by reducing the health impact of its business through offering a greater choice of enjoyable and less risky products for adult consumers.

 

The company continues to be clear that combustible cigarettes pose serious health risks, and the only way to avoid these risks is not to start or to quit. BAT encourages those who would otherwise continue to smoke to switch completely to scientifically-substantiated, reduced-risk alternatives*†. In order to deliver this, BAT is transforming into a truly consumer-centric multi-category consumer products business.

 

BAT’s ambition is to have 50 million consumers of its non-combustible products by 2030 and to generate £5billion of New Categories revenue by 2025. BAT has set stretching ESG targets including achieving carbon neutrality for Scopes 1 & 2 by 2030 and eliminating unnecessary single-use plastic and making all plastic packaging reusable, recyclable or compostable by 2025.

 

BAT employs over 50,000 people. The BAT Group generated revenue of £27.65 billion in 2022 and profit from operations of £10.5 billion.

 

 
 

 

The company’s Strategic Portfolio is made up of its global cigarette brands and a growing range of reduced-risk*† New Category tobacco and nicotine products and traditional non-combustible tobacco products. These include vapour, tobacco heating products, modern oral products including tobacco-free nicotine pouches, as well as traditional oral products such as snus and moist snuff. In 2022, we had 22.5 million consumers of our non-combustible products, a rise of 4.2 million from Full Year 2021.

 

* Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.

† Our vapour product Vuse (including Alto, Solo, Ciro and Vibe), and certain products, including Velo, Grizzly, Kodiak, and Camel Snus, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.

 

 

About AJNA BioSciences PBC

AJNA BioSciences PBC is a botanical drug development company based in Denver, Colorado, focused on natural pharmaceuticals that address mental health and neurological disorders. AJNA’s unique platform is designed for rapid development of investigational new drugs by combining specialized laboratory infrastructure and CMC capabilities with top-tier clinical and regulatory expertise. AJNA’s commercialization strategy is flexibly designed for co-development partnerships, IP licensing, and vertically integrated drug products in a broad range of botanical species and clinical indications. As a public benefit corporation, AJNA’s business model maximizes profitability and sustainability for both people and planet.

 

About Charlotte’s Web Holdings, Inc.

Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Denver, is the market leader in innovative hemp extract wellness products under a family of brands that includes Charlotte's Web™, CBD Medic™, and CBD Clinic™. Charlotte’s Web whole-plant CBD extracts come in full-spectrum and broad-spectrum (THC-free) options, including the world’s only broad-spectrum CBD certified NSF for Sport®, which is the official CBD of Major League Baseball©. Founded by the seven Stanley Brothers, Charlotte’s Web ignited the CBD industry when the brothers came to global prominence with the coverage of a young girl’s astounding reaction to their hemp extract. Their advocacy changed laws, public perception, and research around the vast health potential of plant-based solutions. The Stanleys built their business with the mission to bring botanical options to health seekers worldwide. Charlotte's Web branded premium quality products start with proprietary hemp genetics that are American farm-grown using organic and regenerative cultivation practices. The Company's hemp extracts have naturally occurring botanical compounds including cannabidiol ("CBD"), CBC, CBG, terpenes, flavonoids, and other beneficial compounds. The Company's CW Labs R&D division advances hemp science at a center of excellence in Louisville, Colorado. Charlotte’s Web product categories include CBD oil tinctures (liquid products) CBD gummies (sleep, stress, exercise recovery), CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with 20+ product lot testing for quality assurance. Charlotte’s Web products are distributed to retailers and health care practitioners throughout the U.S.A, and online through the Company's website at www.charlottesweb.com.

 

© Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

 

Forward-Looking Information

Certain information in this news release constitutes forward-looking statements and forward-looking information within the meaning of applicable securities laws (collectively, ‎‎"forward-looking information"). In some cases, but not necessarily in all cases, forward looking information can be identified by the ‎use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", ‎‎"is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and ‎phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be ‎achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or ‎circumstances contain forward-looking information. ‎ Specifically, this ‎news release contains forward-looking statements relating to, among others, the ability of the JV to achieve its purpose, including obtaining FDA approval of a new CBD-based botanical drug.

 

 
 

 

Statements containing forward-looking information are not historical facts, but instead represent management's current ‎expectations, estimates and projections regarding the future of our business, future plans, strategies, projections, anticipated events ‎and trends, the economy and other future conditions. Forward-looking information is necessarily based on a number of opinions, ‎assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to ‎known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, ‎performance or achievements to be materially different from those expressed or implied by such statements containing forward-looking information. Although these statements containing forward-looking information are based on assumptions the Company considers to be reasonable based on the information ‎available on the date such statements are made, such statements are not guarantees of future performance and readers are cautioned ‎against placing undue reliance on forward-looking information.

 

The material factors and assumptions used to develop the forward-looking information herein include, but are not limited to, international and political considerations; regulatory changes; ‎and the factors discussed throughout the "Risk Factors" section of the Company's most recently filed annual information form available on www.SEDAR.com and in the Company's most recently filed Annual Report on Form 10-K and quarterly report on Form 10-Q as amended, and other filings with the Securities and Exchange Commission available on www.SEC.gov. Except as required by applicable securities laws, the Company undertakes no obligation to publicly update any forward-looking information, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

 

For further information contact:

 

Charlotte’s Web

Cory Pala

Director of Investor Relations

(720) 484-8930

Cory.Pala@CharlottesWeb.com

 

AJNA BioSciences Media Contact

ICR

Michael Robinson

(202) 255-0737

MichaelW.Robinson@icrinc.com

 

GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg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cwbhf-20230406.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 cwbhf-20230406_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 cwbhf-20230406_pre.xml EX-101.PRE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Apr. 06, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 06, 2023
Entity File Number 000-56364
Entity Registrant Name Charlotte’s Web Holdings, Inc.
Entity Central Index Key 0001750155
Entity Tax Identification Number 98-1508633
Entity Incorporation, State or Country Code A1
Entity Address, Address Line One 700 Tech Court
Entity Address, City or Town Louisville
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80027
City Area Code 720
Local Phone Number 617-7303
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
XML 8 form8k_htm.xml IDEA: XBRL DOCUMENT 0001750155 2023-04-06 2023-04-06 iso4217:USD shares iso4217:USD shares 0001750155 false A1 true 8-K 2023-04-06 Charlotte’s Web Holdings, Inc. 000-56364 98-1508633 700 Tech Court Louisville CO 80027 720 617-7303 false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://charlottesweb.com/role/Cover Cover Cover 1 false false All Reports Book All Reports [dq-0540-EntityEmergingGrowthCompany-Value] In submission type 8-K, EntityEmergingGrowthCompany value "True", is not equivalent to header element emergingGrowthCompanyFlag value "false" in the Required Context. form8k.htm 22 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityEmergingGrowthCompany, dei:EntityIncorporationStateCountryCode - form8k.htm 21, 22 form8k.htm cwbhf-20230406.xsd cwbhf-20230406_lab.xml cwbhf-20230406_pre.xml ex991.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 20 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8k.htm" ] }, "labelLink": { "local": [ "cwbhf-20230406_lab.xml" ] }, "presentationLink": { "local": [ "cwbhf-20230406_pre.xml" ] }, "schema": { "local": [ "cwbhf-20230406.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 20, "memberCustom": 0, "memberStandard": 0, "nsprefix": "CWBHF", "nsuri": "http://charlottesweb.com/20230406", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8k.htm", "contextRef": "From2023-04-06to2023-04-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://charlottesweb.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8k.htm", "contextRef": "From2023-04-06to2023-04-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://charlottesweb.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001279569-23-000434-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001279569-23-000434-xbrl.zip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